Clinical Trials Browser

Phase 1 × INDUSTRY × Cancer Cachexia (CC) × Clear all

NCT07237464 2025-11-19

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants

Phase 1 Recruiting

Cancer Cachexia (CC)